
Opinion|Videos|April 1, 2024
Impact of Novel Medications and Out-Of-Pocket Costs in Managing Cardiovascular Disease
Panelists discuss financial obstacles, out-of-pocket costs, prior authorizations, and the inpatient/outpatient care paradigm.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
2
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
3
Lipid Management Remains Central to Cardiovascular Risk Reduction in CKD
4
Inside the 24-Hour Reversal of SAMHSA Grant Cuts With NAMI's Jennifer Snow, MPA
5




























































